Načítá se...
Hyperprogression after immunotherapy
INTRODUCTION: Checkpoint inhibitors demonstrate very good anticancer effects, and some patients are long-time responders. As our experience to use these drugs increases, we see more and more patients having different kind of side effects which are usually not seen with chemotherapy. We have observed...
Uloženo v:
| Vydáno v: | South Asian J Cancer |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer - Medknow
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6852633/ https://ncbi.nlm.nih.gov/pubmed/31807489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_389_18 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|